HomeXERS • NASDAQ
add
Xeris Biopharma Holdings Inc
Previous close
$6.72
Day range
$6.47 - $6.80
Year range
$3.14 - $10.08
Market cap
1.08B USD
Avg Volume
2.60M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 74.38M | 37.06% |
Operating expense | 56.65M | 5.76% |
Net income | 621.00K | 103.95% |
Net profit margin | 0.83 | 102.86% |
Earnings per share | 0.00 | 100.00% |
EBITDA | 9.78M | 199.04% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 91.60M | 31.98% |
Total assets | 370.19M | 15.29% |
Total liabilities | 371.05M | 6.19% |
Total equity | -861.00K | — |
Shares outstanding | 165.92M | — |
Price to book | -672.00 | — |
Return on assets | 4.77% | — |
Return on capital | 6.80% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 621.00K | 103.95% |
Cash from operations | 18.43M | 321.94% |
Cash from investing | -71.00K | -100.72% |
Cash from financing | 13.85M | 16,786.75% |
Net change in cash | 32.21M | 2,010.81% |
Free cash flow | 26.13M | 914.54% |
About
Founded
2005
Headquarters
Website
Employees
394
